CONTAK RENEWAL 3 AVT
NCT00158977 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 73
Last updated 2011-09-29
Summary
The RENEWAL 3 AVT device is designed to treat patients suffering from HF, with a history of or at risk of developing atrial and ventricular arrhythmias
Conditions
Interventions
- DEVICE
-
CONTAK RENEWAL 3 AVT
CONTAK RENEWAL 3 AVT
Sponsors & Collaborators
-
Boston Scientific Corporation
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
- Primary Completion
- 2004-10-31
- Completion
- 2008-02-29
Countries
- United States
Study Locations
More Related Trials
-
Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation
NCT00387803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251 ·Status: COMPLETED ·Phase: NA
-
Restoring Sinus Rhythm With Cardiac Resynchronization in Patients With Atrial Fibrillation (ReSync AF)
NCT00268294 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead
NCT00158938 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
MOMENTUM 3 Continued Access Protocol
NCT02892955 ·Status: COMPLETED ·Phase: NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195 ·Status: RECRUITING ·Phase: NA
-
Interventricular Delay of Lumax HF-T for Heart Failure
NCT00508391 ·Status: COMPLETED ·Phase: PHASE2
-
Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
NCT05015764 ·Status: COMPLETED ·Phase: NA
-
Mobile Advanced Multi-Parameter Reporting in Patients Wearing a Novel Device: Utilization During Cardiac Rehabilitation
NCT05957172 ·Status: WITHDRAWN
-
Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
NCT00115843 ·Status: WITHDRAWN ·Phase: NA
-
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
NCT00267098 ·Status: COMPLETED ·Phase: NA
-
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
NCT05652218 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients
NCT00345592 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of the BioVentrix Revivent TC for the Treatment of Ischemic Cardiomyopathy
NCT02553785 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
NCT03247829 ·Status: COMPLETED
-
REmodeling the Left Ventricle With Atrial Modulated Pacing
NCT03210402 ·Status: COMPLETED ·Phase: NA
-
RethinQ Study - Evaluating Pacing in Heart Failure Patients
NCT00132977 ·Status: COMPLETED ·Phase: PHASE3
-
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
NCT02700880 ·Status: COMPLETED
-
BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement
NCT00929474 ·Status: TERMINATED ·Phase: NA
-
Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure
NCT00814840 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The REACT-ICD Trial
NCT02439424 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
NCT00305214 ·Status: COMPLETED ·Phase: NA
-
Randomized Evaluation and Verification of Ventricular Enhancement
NCT03845127 ·Status: WITHDRAWN ·Phase: NA
-
Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failure With Preserved Ejection Fraction
NCT03338374 ·Status: COMPLETED ·Phase: NA
-
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
NCT00156728 ·Status: COMPLETED ·Phase: PHASE4